{"id":"NCT00980798","sponsor":"Janssen-Cilag International NV","briefTitle":"Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee","officialTitle":"Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Investigate the Analgesic Effect of OROS Hydromorphone Hydrochloride in Comparison With Placebo in Subjects With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2009-09-21","resultsPosted":"2010-09-06","lastUpdate":"2014-04-25"},"enrollment":288,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Osteoarthritis, Hip","Osteoarthritis, Knee"],"interventions":[{"type":"DRUG","name":"OROS hydromorphone HCl","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"PLACEBO_COMPARATOR"}],"summary":"This clinical trial tests the pain relieving effectiveness of OROS hydromorphone, a once-daily formulation of a strong opioid against placebo in patients, who are suffering from pain due to osteoarthritis of the hip or the knee and who previously did not receive any strong opioids.The clinical trial tests the effect of the treatment on symptoms of pain, stiffness and physical function. The effect of the treatment on parameters on health related quality of life as well as quality of sleep will be measured.","primaryOutcome":{"measure":"Analgesic Effect as Assessed by Brief Pain Inventory (BPI) Item 5 Score (Pain on Average)","timeFrame":"At each study visit from screening to week 16","effectByArm":[{"arm":"Placebo","deltaMin":6.4,"sd":0.94},{"arm":"OROS Hydromorphone HCl","deltaMin":6.4,"sd":1.05}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1212"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":12,"countries":["Czechia","Romania","Slovakia","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=48&filename=CR012601_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":149},"commonTop":["Constipation","Somnolence","Nausea","Dizziness","Dry mouth"]}}